Beasley Allen has filed an opioid lawsuit against drug manufacturers and distributors on behalf of the Town of Yellow Bluff, Alabama. The lawsuit alleges the marketing of these drugs contributed to the creation of the opioid epidemic, a public health and safety crisis. Responding to the opioid crisis has required the city to sustain economic damages and to continue to bear a significant financial burden. The Town of Yellow Bluff is represented by Beasley Allen lawyers Rhon E. Jones, who is head of the firm’s Toxic Torts Section, Rick Stratton, Will Sutton, Ryan Kral and LaBarron Boone, along with William M. Pompey and Brenda M. Pompey of Pompey & Pompey law firm in Camden, Alabama.
Beasley Allen has filed similar lawsuits on behalf of the City of Greenville, Houston County, Barbour County, Limestone County, City of Anniston, and City of Evergreen, Alabama, as well as Sumner County, Tennessee. The firm also is representing the State of Alabama in its opioid lawsuit against Purdue Pharmaceuticals.
“This opioid crisis was created by the pharmaceutical industry, which clearly put its interests in profit ahead of concerns for public safety,” Jones said. “They overstated the benefits of these drugs while downplaying the risks. As a result, even when opioids are prescribed for legitimate medical reasons, their high propensity for addiction often leads to their abuse.”
“Communities throughout the country are struggling to provide essential services to people affected by the opioid epidemic. This crisis touches so many lives, people of all ages and from all walks of life,” Pompey said. “They need help, and towns like Yellow Bluff are overwhelmed in their efforts to meet these needs.”
Economic damages resulting from the opioid epidemic include costs for providing medical care, therapeutic care and treatments for patients suffering from opioid-related addiction or disease, including overdoses and deaths; costs for providing counseling and rehabilitation services; costs for treating infants born with opioid-related medical conditions; public safety and law enforcement expenses; and care for children whose parents suffer from opioid-related disability or incapacitation.
In 2016, Wilcox County, where the Town of Yellow Bluff is located, had an opioid prescription rate of 66.4 for every 100 people. Four Alabama cities rank in the Top 15 places in the nation with the highest rates of opioid abuse – Anniston, Gadsden, Montgomery and Tuscaloosa. Nationally, oioids are responsible for killing more than 183,000 people isince 1999, according to the Centers for Disease Control and Prevention (CDC). In 2016 alone, 42,000 people in the U.S. died from opioid overdoses.
Defendants include Purdue Pharma L.P.; Purdue Pharma, Inc.; The Purdue Frederick Company, Inc.; Teva Pharmaceutical Industries, LTD.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; Janssen Pharmaceutical Inc. n/k/a Janssen Pharmaceuticals, Inc.; Noramco, Inc.; Endo Health Solutions Inc.; Endo Pharmaceuticals, Inc.; Allergan PLC f/k/a Actavis PLS; Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc.; Watson Laboratories, Inc.; Actavis, LLC; Actavis Pharm a, Inc. f/k/a Watson Pharma, Inc.; Mallinckrodt plc; Mallinckrodt LLC; McKesson Corporation; Cardinal Health, Inc.; and AmerisourceBergen Drug Corporation.
The complaint is filed in the U.S. District Court for the Southern District of Alabama.